Back to the main directory
Press Release
- PolyPid Announces Scheduling of Type D Meeting with U.S. FDA to Discuss SHIELD I Phase 3 Results and Regulatory Pathway for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Colorectal Surgery by GlobeNewsWire
- EQS-News: Poolbeg Pharma receives initial results from human challenge clinical study by EQS Group AG
- Photocat signs first sales partnership agreement in the Middle East by GlobeNewsWire
- EQS-News: Touchstone Exploration to restart drilling after raising $13mln by EQS Group AG
- EQS-News: Oriole Resources delivers 'first-ever JORC mineral resource estimate for orogenic gold in Cameroon' by EQS Group AG
- WisdomTree Reports Monthly Metrics for November 2022 by GlobeNewsWire
- Virco Reports Third Quarter Revenue Increased 35%, Driving Improved Financial Performance Across Multiple Metrics by GlobeNewsWire
- Daktronics, Inc. Announces 2023 Fiscal Second Quarter Results, Details Liquidity Enhancement Program by GlobeNewsWire
- GT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022 by GlobeNewsWire
- Cardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx(TM) for the Treatment of Recurrent Pericarditis by Newsfile Corp.
- Coinsilium Group Limited: Result of AGM and Statement by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc by EQS Group AG
- UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc. by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Biffa plc by EQS Group AG
- EROLD SA : Décès de Thierry Casseville, co-fondateur et Directeur Général du Groupe by GlobeNewsWire
- NICE Launches Enlighten AutoSummary, Empowering Agents To Deliver Seamless CX by BusinessWire
- Michelin: Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital by GlobeNewsWire
- STMicroelectronics Announces Status of Common Share Repurchase Program by GlobeNewsWire
- Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company by GlobeNewsWire
- Ackroo to acquire Simpliconnect by GlobeNewsWire
- Caribou Biosciences Selects ROR1 as the Target for CB-020, an iPSC-derived Allogeneic CAR-NK Cell Therapy by GlobeNewsWire
- Baker Hughes Added to the Nasdaq-100 Index by GlobeNewsWire
- CN’s Leadership in Sustainability Recognized, Named to the Dow Jones Sustainability World Index for 11th Straight Year by GlobeNewsWire
- Magenta Therapeutics to Host Conference Call and Webcast on Tuesday, December 13, 2022, to Review MGTA-117 Clinical Data from Ongoing Phase 1/2 Clinical Trial by GlobeNewsWire
- Daré Bioscience Announces New Development Program, DARE-PDM1, as a Potential First-in-Category Treatment for Primary Dysmenorrhea by GlobeNewsWire